期刊
EXPERT OPINION ON PHARMACOTHERAPY
卷 10, 期 7, 页码 1191-1202出版社
TAYLOR & FRANCIS LTD
DOI: 10.1517/14656560902928896
关键词
aerosolised antibiotics; anti-inflammatory; CFTR modulation; cystic fibrosis; mucus regulation; new therapies
Cystic fibrosis (CF) is an inherited disease, characterised by pancreatic malabsorption (with poor growth) and impaired mucociliary clearance (leading to recurrent pulmonary infection). The prognosis has markedly improved over the last 40 years. This was achieved initially by improving pancreatic enzyme supplements and more recently through drugs designed to treat pulmonary infection, reduce inflammation and enhance mucociliary clearance. The CF gene has been sequenced, allowing new therapeutic targets to be identified. Currently the greatest therapeutic challenges are to correct the biochemical defect of CF and to identify effective treatments for chronic respiratory infection. This review provides an overview of CF, the treatment strategies currently used, and new drugs undergoing clinical trials.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据